REAL LAM – HCV positive donors in HCV negative recipients and ex-vivo machine perfusion for liver preservation
Second Spanish REAL webinar for Latin America on 27 May on HCV positive donors in HCV negative recipients and ex-vivo machine perfusion for liver preservation by Manuel Mendizabal and Nicolás Goldaracena.
27 May 2021
12:00 am CDMX (Ciudad de México)
02:00 pm ART (Argentina Time)
07:00 pm CET (Central European Time)
This webinar will be held in Spanish!
In the second Regional Expansion of Advanced Learning project for Latin America, we target topics of great interest for the transplant community. Issues such as liver transplantation using HCV positive donors in HCV negative recipients and ex-vivo machine perfusion for liver preservation, especially important in Latin America, a region with low organ donation.
Join us at the second ILTS REAL Webinar for Latin America!
This webinar is a collaboration between ILTS and ALEH (Asociación Latinoamericana para el Estudio del Hígado).
- Become familiarized with liver transplantation using HCV positive donors in HCV negative recipients
- Learn about ex-vivo machine perfusion for liver preservation
- INTRODUCTION | Roberto Hernandez-Alejandro, Juan Pablo Arab
- SESSION 1 | “Liver Transplantation: HCV positive donors in HCV negative recipients” – Manuel Mendizabal
- Q&A Part 1 with Manuel Mendizabel and Ezequiel Mauro
- SESSION 2 |”Ex-vivo machine perfusion for liver preservation” – Nicolás Goldaracena
- Q&A Part 2 with Nicolás Goldaracena and Martín Dib
- CONCLUSION | Roberto Hernandez-Alejandro, Juan Pablo Arab
|Roberto Hernandez-Alejandro is Chief of the Division of Transplantation at the University of Rochester (URMC) since August 2016. There, he’s demonstrated his ability to grow a program, leading his team to double the number of organ transplants with the best outcomes in the program’s history. Under his leadership, URMC restarted live donor liver transplants, performing 30 operations over 2.5 years as well as introducing a very active program of donation after cardiac death. Dr. Hernandez is also heavily focused on liver resections, and is one of a handful of US surgeons performing the ALPPS procedure. Dr. Hernandez recently opened the second active program on liver transplantation for unresectable colorectal liver metastases in the US. Dr. Hernandez has received multiple grants for innovative research in liver cancer and regeneration and has >100 peer-reviewed publications in HPB and liver transplantation. In 2019, he joined the editorial board of Annals of Surgery, the highest impact factor surgical journal. Dr. Hernandez has positions in many societies, including the Scientific Committee of the ALPPS Registry, Chair of the ILTS Education & Scholarship Committee, and President of the New York Liver Transplant Consortium.|
|Juan Pablo Arab, Professor of Medicine at the Pontificia Universidad Catolica de Chile School of Medicine. Trained at the Pontificia Universidad Catolica, Chile and Mayo Clinic, Rochester, MN, USA. Dr. Arab is a Transplant Hepatologist and Physician Scientist with an interest in translational and clinical research in alcohol-related liver disease and non-alcoholic fatty liver disease. He is the Director for Living Donor Liver Transplantation at his institution. He has published more than 100 peer-reviewed papers on gastrointestinal and liver diseases in high-impact factor journals, several book chapters and delivered lectures at national and international meetings. He is the Vice-President of the Chilean Hepatology Association and member of the Education & Scholarship Committee of the International Liver Transplantation Society (ILTS).|
|Manuel Mendizabal currently works as a hepatologist at the Hepatology and Liver Transplantation Unit of the Austral University Hospital in Buenos Aires. He received his medical degree from Austral University and completed his Internal Medicine residency at the same Institution. He subsequently completed his training in Hepatology and Liver Transplantation at the University of Pennsylvania under the direction of Dr. Rajender Reddy. He is part of the different regional scientific societies, being currently the Secretary of the Latin American Association for the Study of the Liver (ALEH) and the Secretary of the Argentine Society for the Study of Liver (SAHE). His areas of interest are viral hepatitis, acute liver failure, and liver transplantation having more than 90 publications in scientific journals and book chapters.|
Nicolás Goldaracena, MD, serves as surgical director of the UVA Living Donor Liver Transplant Program and UVA Pediatric Liver Transplant Program. He joined UVA in 2019, bringing a unique set of skills with special training in living donor liver transplantation, pediatric liver transplantation and complex hepato-pancreato-biliary surgery to address benign and malignant diseases of the liver, pancreas, bile ducts and gallbladder. His clinical practice focuses on living donor hepatectomy, living donor liver transplantation, pediatric liver transplant, and liver cancer and pancreatic surgery. Dr. Goldaracena’s research is focused on clinical outcomes of adult and pediatric liver transplantation. He has a special interest in increasing the donor organ pool and reducing mortality among those on liver transplant waiting lists by advancing living donor liver transplantation.
His research interests also include living donor safety and the outcome of and access to transplantation for patients suffering from primary or metastatic liver cancer.
Ezequiel Mauro, MD, MSc and PhD in progress at University of Barcelona. He is a physician in Hepatology and Liver Transplant at the Hospital Italiano from Buenos Aires. He trained at the Hospital Italiano, Bs As, Argentina and Hospital Clinic, Barcelona, Spain. Dr. Mauro is a specialist in Internal Medicine and Hepatology, Transplant Hepatologist and physician-scientist interested in clinical research in Cirrhosis, ACLF, Sarcopenia, and Liver Transplantation. He is the Director of the National Program of Viral Hepatitis of the Ministry of Health of Argentina. He has a great number of peer-reviewed papers on gastrointestinal and liver designs in high-impact factor journals, co-authored books chapters and delivered lectures on liver-related topics at national and international meetings. He has also participated in the development of Clinical Practice Guidelines of Viral Hepatitis and regularly participated as an expert reviewer of research grants and scientific research abstracts for multiple Societies, Funding Agencies and International Peer-Reviewed Journals.
|Martín Dib graduated from medical school at University of Chile, after which he did a Research Fellowship in Liver Regeneration at Harvard University. He completed his General Surgery Residency at Beth Israel Deaconess Medical Center, Harvard University and his Clinical Fellowship in Abdominal Organ Transplant and Hepato-Pancreato-Biliary Surgery at the University of Toronto. He worked as a Transplant Surgeon and Assistant Professor of Surgery at the University of Wisconsin-Madison, and in 2018 moved back to Chile to develop a Live Donor Liver Transplant Program in Latin America and is currently the Chief of Transplant at Pontificia Universidad Catolica de Chile.|